Abstract
We aimed to examine rates of breast and cervical cancer screening in women with immune-mediated inflammatory diseases (IMID), including inflammatory bowel disease (IBD), multiple sclerosis (MS) and rheumatoid arthritis (RA) versus a matched cohort with IMID; and examine the association of psychiatric comorbidity with screening in these populations. We conducted a retrospective cohort study in Manitoba, Canada using administrative data. We identified women with IBD, MS and RA, and controls without these IMID matched on age and region. Annually, we identified individuals with any active mood/anxiety disorder. Using physician claims, we determined the proportion of each cohort who had cervical cancer screening within three-year intervals, and mammography screening within two-year intervals. We modeled the difference in the proportion of the IMID and matched cohorts who underwent mammography; and pap tests using log-binomial regression with generalized estimating equations, adjusting for sociodemographics, comorbidity and immune therapy use. We tested for additive interactions between cohort and mood/anxiety disorder status. During 2006–2016, we identified 17,230 women with IMID (4,623 with IBD, 3,399 with MS, and 9,458 with RA) and 85,349 matched controls. Having an IMID was associated with lower (-1%) use of mammography; however, this reflected a mixture of more mammography in the IBD cohort (+2.9%) and less mammography in the MS (-4.8 to -5.2%) and RA (-1.5%) cohorts. Within the IBD, MS and RA cohorts, having an active mood/anxiety disorder was associated with more mammography use than having an inactive mood/anxiety disorder. The MS and RA cohorts were less likely to undergo Pap testing than their matched cohorts. In the absence of an active mood/anxiety disorder, the IBD cohort was more likely to undergo Pap testing than its matched cohort; the opposite was true when an active mood/anxiety disorder was present. Among women with an IMID, mood/anxiety disorder influence participation in cancer screening.
Highlights
Preventive care, such as cancer screening and immunizations, is important for prevention and early identification of potentially life-threatening disease
Within the inflammatory bowel disease (IBD), multiple sclerosis (MS) and rheumatoid arthritis (RA) cohorts, having an active mood/anxiety disorder was associated with more mammography use than having an inactive mood/anxiety disorder
Participation in screening was relatively low and having an immune-mediated inflammatory disease (IMID) was associated with slightly (1%) lower use of mammography; this reflected an average effect of greater use of mammography in the IBD cohort (2.9%) and lower use in the MS (4.8–5.2%) and RA (1.5%) cohorts
Summary
Preventive care, such as cancer screening and immunizations, is important for prevention and early identification of potentially life-threatening disease. Persons with chronic conditions may have lower rates of preventive care than the general population. The influence of immune-mediated inflammatory disease (IMID), such as inflammatory bowel disease (IBD), multiple sclerosis (MS) and rheumatoid arthritis (RA), on use of preventive care is poorly understood but this knowledge is important to inform interventions that support preventive care in clinical practice in these populations. Prior studies have had conflicting findings [2, 3]. These studies often included small samples, lacked control groups to account for use of preventive care in the general population, or were not recent enough to reflect current practice [3, 4]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.